Details of the Drug Reposition

General Information of This Drug (ID: DME0XSP)

Drug Name
STI-001   DME0XSP
Synonyms
AP4-24H11; STI-001 program (mAbs targeting S aureus auto-inducing peptides); Fully human anti-AIP monoclonal antibody (MRSA/bacterial infections), Sorrento Therapeutics; Quorum sensing-targeting antibodies (MRSA/bacterial infections), Sorrento Therapeutics; STI-001 program (mAbs targeting S aureus auto-inducing peptides), Sorrento Therapeutics

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Colorectal cancer DISNH7P9 2B91.Z Phase 3 [1]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Bacterial infection DIS5QJ9S 1A00-1C4Z Investigative [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.